Russian Pharmaceutical Industry Leader
About
Products
Press center
R&D
Career
Antifraud
Export
Contacts
News
Media publications
Information materials
Terms of use
Home
Press center
News
Аll
Pharmasyntez Group
JSC Pharmasyntez
JSC Pharmasyntez-Nord
LLC Pharmasyntez-Tyumen
LLC East-Pharm
LLC Bratskhimsyntez
Export
Аll
2024
2023
2022
2021
2020
2019
2018
2017
15.12.2022
Oleg Astafurov: “Bringing an innovative drug to market can be compared to building an entire plant”
Read more
14.12.2022
Prospects in the fight against tuberculosis
Read more
13.12.2022
Pharmasyntez ranked second in the rating of doctors’ trust in pharmaceutical companies
Read more
07.12.2022
Skolkovo start-ups will receive mentorship and expert support from pharmaceutical industry professionals
Read more
25.11.2022
Nomides® (INN Oseltamavir), a drug for the treatment of influenza, ranked 2d place winner at the Russian Pharma Awards®
Read more
18.11.2022
The 26th Russian Oncology Congress
Read more
15.11.2022
Pharmasyntez became a winner of GхP-Profi 2022 International Innovation Competition
Read more
30.09.2022
Pharmasyntez took part in the main event of the year for gynecologists
Read more
30.09.2022
Pharmasyntez took part in OpenBio 2022
Read more
23.09.2022
Industrial partnership with the Skolkovo Foundation
Read more
20.09.2022
Vikram Punia: KSM may become available in Russia
Read more
20.09.2022
Pharmasyntez presented a unique portfolio of hormonal drugs at Biotechmed
Read more
11.09.2022
Pharmasyntez and Eurasian Academy of Good Practices signed a network contract
Read more
08.09.2022
Consistency of approaches to adequate quality
Read more
03.08.2022
Pharmasyntez is the Prime Sponsor of the VII All-Russian GMP Conference
Read more
19.06.2022
Congratulations to healthcare professionals on their professional day!
Read more
News:
← предыдущая
1
2
3
следующая →
About
History
Production
JSC Pharmasyntez
LLC EAST-PHARM
LLC PHARMASYNTEZ-TYUMEN
JSC PHARMASYNTEZ-NORD
LLC BratskChemSyntez
Quality management
Management
Social projects
Products
Anti-TB
Antibiotics
Cardiology
Corticoid hormones
COVID-19
Drugs for the treatment of diabetes mellitus
Endocrinology
Gynecology
HIV treatment
Infusion solutions
Injectable solutions
Local anesthetic agents
MRI agents
Multiple sclerosis
Neuroleptics
Neurology
Nonsteroidal anti-inflammatory drug
Nootropics
Oncology
Systemic mycoses
Therapeutic drugs
Transplantology
Treatment of hepatitis B
X-ray contrast agents
Сообщить о нежелательном явлении
Заполнить анкету по качеству
Press center
Pharmasyntez Group
JSC Pharmasyntez
JSC Pharmasyntez-Nord
LLC Pharmasyntez-Tyumen
LLC East-Pharm
LLC Bratskhimsyntez
Export
R&D
R&D co-operation
Intellectual property
Publications
Career
Personnel policy
Training and career development
Antifraud
Export
Possibilities
News
Contacts
Head office
Moscow Office
East-Pharm
Pharmasyntez-Tyumen
Pharmasyntez-Nord
BratskChemSyntez